首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer
【24h】

A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer

机译:与人结直肠癌中DNMT3B异常启动子DNA高甲基化相关的DNA甲基化签名

获取原文
获取原文并翻译 | 示例
           

摘要

Altered promoter DNA methylation, one of the most important molecular alterations in cancer, is proposed to correlate with deregulation of DNA methyltransferases, although the molecular mechanisms implicated are still poorly understood. Here we show that the de novo DNA methyltransferase DNMT3B is frequently repressed in human colorectal cancer cell lines (CCL) and primary tumours by aberrant DNA hypermethylation of its distal promoter. At the epigenome level, DNMT3B promoter hypermethylation was associated with the hypomethylation of gene promoters usually hypermethylated in the healthy colon. Forced DNMT3B overexpression in cancer cells restored the methylation levels of these promoters in the healthy colon. Our results show a new molecular mechanism of aberrant DNMT3B regulation in colon cancer and suggest that its expression is associated with the methylation of constitutively hypermethylated promoters in the healthy colon.
机译:改变的启动子DNA甲基化,癌症中最重要的分子改变之一,也提出与DNA甲基转移酶的放液相同相关,尽管涉及的分子机制仍然是较差的。 在这里,我们表明DE Novo DNA甲基转移酶DNMT3B经常通过其远端启动子的异常DNA高甲基化在人结肠直肠癌细胞系(CCL)和原发性肿瘤中抑制。 在表观蛋白酶体水平,DNMT3B启动子高甲基化与通常在健康结肠中的基因启动子的低甲基化相关。 癌细胞中强迫DNMT3B过表达恢复了健康结肠中这些启动子的甲基化水平。 我们的结果表明,结肠癌中异常DNMT3B调节的新分子机制,表明其表达与健康结肠中组成型高甲基化促进剂的甲基化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号